CD3/CD28 costimulated autologous T-cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD3/CD28 costimulated autologous T-cells, covering 2017-05-02 to 2017-05-02. Get the full timeline:
Most recent: Clinical Trial Update: DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1, Phase 2]